Alpha Tau Medical (DRTS) Times Interest Earned (2021 - 2026)
Alpha Tau Medical (DRTS) posted Times Interest Earned of $0.56 for Q4 2025, down 43.66% sequentially from $0.99 in Q2 2025, and down 61.33% YoY from $1.44 in Q4 2024.
Alpha Tau Medical (DRTS) Times Interest Earned (2021 - 2026) Analysis & Trends
Alpha Tau Medical has reported Times Interest Earned for 5 years, with the latest figure at $0.56 in Q4 2025.
- Quarterly Times Interest Earned fell 61.33% year-over-year to $0.56 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.87 (down 63.01% YoY) and the FY2025 annual result came in at $1.87, down 50.6% from the prior year.
- Times Interest Earned fell to $0.56 in Q4 2025 per DRTS's latest filing, from $0.99 in the prior quarter.
- Over five years, Times Interest Earned peaked at $683.75 in Q1 2021 and troughed at $0.56 in Q4 2025.
- A 5-year average of $137.24 and a median of $1.47 in 2023 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2023: Times Interest Earned surged 51.48% in 2022, then plunged 99.74% in 2023.
- Over 5 years, Times Interest Earned stood at $1.04 in 2021, then soared by 51.48% to $1.57 in 2022, then advanced by 8.46% to $1.7 in 2023, then fell by 15.47% to $1.44 in 2024, then sank by 61.33% to $0.56 in 2025.
- According to Business Quant data, Times Interest Earned over the past three periods registered $0.56, $0.99, and $1.44 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - | -0.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.30 |
| Dec 31, 2025 | 0.56 |
| Jun 30, 2025 | 0.99 |
| Dec 31, 2024 | 1.44 |
| Jun 30, 2024 | 0.92 |
| Dec 31, 2023 | 1.70 |
| Jun 30, 2023 | 1.47 |
| Dec 31, 2022 | 1.57 |
| Jun 30, 2022 | 572.29 |
| Mar 31, 2022 | 243.92 |
| Dec 31, 2021 | 1.04 |
| Mar 31, 2021 | 683.75 |